EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $342,261 | -38.4% | 17,606 | -10.2% | 0.00% | -40.0% |
| Q1 2023 | $555,995 | -2.9% | 19,598 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $572,850 | +5.9% | 19,598 | -4.2% | 0.01% | +25.0% |
| Q3 2022 | $541,000 | -23.0% | 20,459 | +29.3% | 0.00% | -20.0% |
| Q2 2022 | $703,000 | -10.2% | 15,827 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $783,000 | +89.6% | 15,827 | +95.1% | 0.00% | +33.3% |
| Q4 2021 | $413,000 | +2.5% | 8,113 | -3.4% | 0.00% | -40.0% |
| Q2 2020 | $403,000 | -46.9% | 8,400 | -49.1% | 0.01% | -61.5% |
| Q1 2020 | $759,000 | -44.5% | 16,500 | -27.5% | 0.01% | +8.3% |
| Q4 2019 | $1,367,000 | -36.7% | 22,750 | -40.4% | 0.01% | -40.0% |
| Q3 2019 | $2,161,000 | +16.9% | 38,200 | +15.0% | 0.02% | +17.6% |
| Q2 2019 | $1,849,000 | +50.7% | 33,211 | +36.7% | 0.02% | +54.5% |
| Q1 2019 | $1,227,000 | +182.1% | 24,300 | +125.0% | 0.01% | +120.0% |
| Q4 2018 | $435,000 | -60.8% | 10,800 | -32.5% | 0.01% | -44.4% |
| Q3 2018 | $1,109,000 | -34.8% | 16,000 | -28.9% | 0.01% | -40.0% |
| Q2 2018 | $1,702,000 | +7.7% | 22,500 | -25.0% | 0.02% | 0.0% |
| Q1 2018 | $1,581,000 | -64.2% | 30,000 | -63.7% | 0.02% | -61.5% |
| Q4 2017 | $4,418,000 | +32.5% | 82,700 | +47.9% | 0.04% | +25.8% |
| Q3 2017 | $3,334,000 | – | 55,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |